Safety of Chronic Cardiac Ryanodine Receptor Modulation: A 10-Year Experience

JACC Clin Electrophysiol. 2018 Nov;4(11):1480-1481. doi: 10.1016/j.jacep.2018.08.001.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Calcium Channel Blockers / adverse effects*
  • Calcium Channel Blockers / therapeutic use
  • Dantrolene / adverse effects*
  • Dantrolene / therapeutic use
  • Electrocardiography
  • Female
  • Heart Diseases / chemically induced
  • Heart Diseases / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Muscle Relaxants, Central / adverse effects*
  • Muscle Relaxants, Central / therapeutic use
  • Muscular Diseases / drug therapy
  • Retrospective Studies
  • Ryanodine Receptor Calcium Release Channel / metabolism*

Substances

  • Calcium Channel Blockers
  • Muscle Relaxants, Central
  • Ryanodine Receptor Calcium Release Channel
  • Dantrolene